Genome‐wide survey of copy number variants finds MAPT duplications in progressive supranuclear palsy
Movement Disorders2019Vol. 34(7), pp. 1049–1059
Citations Over TimeTop 10% of 2019 papers
Zhongbo Chen, Jason Chen, Aleksey Shatunov, Ashley Jones, Stephanie N. Kravitz, Alden Huang, Lauren Lawrence, Jennifer K. Lowe, Cathryn M. Lewis, C. Payán, Wolfgang Lieb, Andre Franke, Panos Deloukas, Philippe Amouyel, Christophe Tzourio, Jean‐François Dartigues, NNIPPS and BBBIPPS Study Groups, Albert Ludolph, Gilbert Bensimon, P. Nigel Leigh, Jeff M. Bronstein, Giovanni Coppola, Daniel H. Geschwind, Ammar Al‐Chalabi
Abstract
Clinicians should also be aware of MAPT duplication as a possible genetic cause of PSP, especially in patients presenting with young age at onset. © 2019 International Parkinson and Movement Disorder Society.
Related Papers
- → Validation of the Movement Disorder Society Criteria for the Diagnosis of 4‐Repeat Tauopathies(2019)69 cited
- → 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy(2003)47 cited
- → Clinical and Pathologic Evidence of Corticobasal Degeneration and Progressive Supranuclear Palsy in Familial Tauopathy(2005)28 cited
- → An autopsy case of Alzheimer's disease with a progressive supranuclear palsy overlap(2000)8 cited
- → Biochemical Evidence for a Pathological Variant of Progressive Supranuclear Palsy(2023)